{
    "eid": "2-s2.0-84901481559",
    "title": "Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity",
    "cover-date": "2014-11-01",
    "subject-areas": [
        {
            "$": "Clinical Biochemistry",
            "@code": "1308"
        },
        {
            "$": "Physiology",
            "@code": "1314"
        },
        {
            "$": "Cell Biology",
            "@code": "1307"
        },
        {
            "$": "Biochemistry (medical)",
            "@code": "2704"
        },
        {
            "$": "Biochemistry",
            "@code": "1303"
        }
    ],
    "keywords": [
        "Cardiovascular",
        "Depression",
        "HDL cholesterol",
        "Metabolic syndrome",
        "Oxidative stress",
        "Paraoxonase 1"
    ],
    "authors": [
        "Chiara Cristina Bortolasci"
    ],
    "citedby-count": 9,
    "ref-count": 63,
    "ref-list": [
        "The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men",
        "Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; And international association for the study of obesity",
        "Bidirectional association between depression and metabolic syndrome: A systematic review and meta-analysis of epidemiological studies",
        "Metabolic syndrome: Connecting and reconciling cardiovascular and diabetes worlds",
        "The metabolic syndrome - A new worldwide definition",
        "Clinical Importance of Obesity Versus the Metabolic Syndrome in Cardiovascular Risk in Women: A Report from the Women's Ischemia Syndrome Evaluation (WISE) Study",
        "BMI versus the metabolic syndrome in relation to cardiovascular risk in elderly Chinese individuals",
        "The metabolic syndrome",
        "Lipid homeostasis, lipotoxicity and the metabolic syndrome",
        "Redox-inflammatory synergy in the metabolic syndrome",
        "Evaluation of oxidative stress in overweight subjects with or without metabolic syndrome",
        "Antioxidant and anti-inflammatory role of paraoxonase 1: Implication in arteriosclerosis diseases",
        "Associations between high density lipoprotein mean particle size and serum paraoxonase--1 activity",
        "Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: A possible peroxidative role for paraoxonase",
        "Human PON1, a biomarker of risk of disease and exposure",
        "Paraoxonases. Ancient Substrate Hunters and Their Evolving Role in Ischemic Heart Disease",
        "Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome",
        "Antioxidant Paraoxonase 1 Activity in the Metabolic Syndrome",
        "Persistent elevation of paraoxonase-1 specific enzyme activity after weight reduction in obese non-diabetic men with metabolic syndrome",
        "Lower Serum Paraoxonase-1 Activity Is Related to Higher Serum Amyloid A Levels in Metabolic Syndrome",
        "Low levels of serum paraoxonase activities are characteristic of metabolic syndrome and may influence the metabolic-syndrome-related risk of coronary artery disease",
        "Circulating levels of adiponectin, orexin-A, ghrelin and the antioxidant paraoxonase-1 in metabolic syndrome",
        "Altered activities of antioxidant enzymes in patients with metabolic syndrome",
        "A functional polymorphism of PON1 interferes with microRNA binding to increase the risk of ischemic stroke and carotid atherosclerosis",
        "Targeting paraoxonase-1 in atherosclerosis",
        "Association between paraoxonase-1 gene polymorphisms and risk of metabolic syndrome",
        "Is it smoking or related lifestyle variables that increase metabolic syndrome risk?",
        "Active Smoking and Risk of Metabolic Syndrome: A Meta-Analysis of Prospective Studies",
        "Associations between smoking, components of metabolic syndrome and lipoprotein particle size",
        "The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence",
        "Smoking is associated with reduced serum levels of the antioxidant enzyme, paraoxonase, in Type 2 diabetic patients",
        "Metabolic syndrome in Italian patients with bipolar disorder",
        "Major depression and the metabolic syndrome",
        "Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways",
        "Maternal and early postnatal nutrition and mental health of offspring by age 5 years: A prospective cohort study",
        "How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: A critical review of biological pathways",
        "Exercising the worry away: How inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours",
        "Preventive strategies in depression: Gathering evidence for risk factors and potential interventions",
        "Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: Relationship with immune-inflammatory markers",
        "Levels of serum total cholesterol and LDL-cholesterol in patients with major depression in acute period and remission",
        "Smoking and mental illness: A population-based prevalence study",
        "Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder",
        "Appropriateness of waist circumference and waist-to-hip ratio cutoffs for different ethnic groups",
        "Rev Bras Psiquiatr",
        "Rev Bras Psiquiatr",
        "The Fagerstr\u00f6m Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire",
        "Determination of paraoxonase 1 status without the use of toxic organophosphate substrates.",
        "Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk",
        "R-carrying genotypes of serum paraoxonase (PON1) 192 polymorphism and higher activity ratio are related to susceptibility against ischemic stroke",
        "Paraoxonase 1 (PON1) polymorphisms, haplotypes and activity in predicting CAD risk in North-West Indian Punjabis",
        "Paraoxonase Arg 192 allele is an independent risk factor for three-vessel stenosis of coronary artery disease",
        "Association of PON1 and APOA5 gene polymorphisms in a cohort of indian patients having coronary artery disease with and without type 2 diabetes",
        "Paraoxonase 1 Gene Polymorphism Does Not Affect Clopidogrel Response Variability but Is Associated with Clinical Outcome after PCI",
        "Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk",
        "Paraoxonase 1 status as a risk factor for disease or exposure",
        "Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities",
        "Methodological constraints in interpreting serum paraoxonase-1 activity measurements: An example from a study in HIV-infected patients",
        "Differential effects of smoking on myocardial infarction risk according to the Gln/Arg 192 variants of the human paraoxonase gene",
        "Human paraoxonase gene cluster polymorphisms as predictors of coronary heart disease risk in the prospective Northwick Park Heart Study II",
        "Association of PON1 and PON2 polymorphisms with pon1 activity and significant coronary stenosis in a tunisian population",
        "Depression and type 2 diabetes over the lifespan: A meta-analysis",
        "Overweight, obesity, and depression: A systematic review and meta-analysis of longitudinal studies",
        "Spurious Genetic Associations"
    ],
    "affiliation": [
        {
            "affiliation-city": "Londrina",
            "affilname": "Universidade Estadual de Londrina",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Melbourne",
            "affilname": "University of Melbourne",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Geelong",
            "affilname": "Deakin University",
            "affiliation-country": "Australia"
        }
    ],
    "funding": []
}